
Tirzepatide vs Semaglutide
01Semaglutide has the stronger cardiovascular outcomes evidence right now — full stop. But tirzepatide produces greater weight loss and broader cardiometabolic improvements, and the gap in hard-endpoint data is narrowing fast.










